首页/数据集/Antiproliferation activities of compounds against breast cancer.

Antiproliferation activities of compounds against breast cancer.

Figshare2024-05-20 更新2026-04-28 收录

数据链接：

https://figshare.com/articles/dataset/Antiproliferation_activities_of_compounds_against_breast_cancer_/25860778 数据链接链接失效反馈

官方服务：

资源简介：

Antiproliferation activities of compounds against breast cancer.

化合物对乳腺癌的抗增殖活性

应用场景：

创建时间：

2024-05-20

乳腺癌药物

传统医学抗癌机制

Breast cancer (BC) is a major public health problem leading cause of cancer death both in Thailand and worldwide. In 2020, BC is the third most common type of cancer in Thailand. The occurrence rate o

NIAID Data Ecosystem60

Evaluation of Novel Synthesized Thiazole Derivatives as Potential Aromatase Inhibitors Against Breast Cancer - supplementary material

乳腺癌药物

芳香酶抑制剂

supplementary figures 1-12 Table S1: The results revealed that PYEEG peptide bound through hydrogen bonds to amino acid residues (Arg134, Arg184, and Arg154). Table S2: The results reveal

DataCite Commons2024-05-16 更新50

Additional file 3: of Association of tamoxifen resistance and lipid reprogramming in breast cancer

乳腺癌药物

肿瘤脂质代谢

Statistical analysis of triglycerides, free cholesterol and cholesterol esters, LMP assay, and LipidToxGreen staining. (XLSX 38 kb)

Figshare2018-08-25 更新50

Selective inhibition of carbonic anhydrase IX activity, using compound SLC-149, displays limited anticancer effects in breast cancer cell lines

碳酸酐酶抑制剂

乳腺癌药物

Selective inhibition of carbonic anhydrase IX activity, using compound SLC-149, displays limited anticancer effects in breast cancer cell lines Descriptor: 4-[3-(2,4-difluorophenyl)-2-oxo-2,3-dihydro-

Protein Data Bank Japan2023-10-11 更新60

Supplementary Table 4 from Pharmacological Profiling of Kinase Dependency in Cell Lines across Triple-Negative Breast Cancer Subtypes

激酶抑制剂药效评估

乳腺癌药物

Supplementary Table 4: Kinase inhibition/inhibitor toxicity association analysis for Group 3 cell lines.

Figshare2015-01-01 更新50